Medtronic plc balance sheet MDT

Annual Quarterly

As of Jul 31, 2026, Medtronic plc had total assets of $93.3 billion and total liabilities of $42.5 billion. Total assets were up 2.6% from a year earlier. Stockholders' equity was $50.2 billion. It held $8.8 billion in cash and investments against $25.6 billion of total debt, net debt of $16.8 billion. The current ratio, current assets divided by current liabilities, was 2.07.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line	FY 2027 Jul 31, 2026	FY 2026 Apr 24, 2026	FY 2025 Apr 25, 2025	FY 2024 Apr 26, 2024	FY 2023 Apr 28, 2023	FY 2022 Apr 29, 2022	FY 2021 Apr 30, 2021	FY 2020 Apr 24, 2020	FY 2019 Apr 26, 2019	FY 2018 Apr 27, 2018	FY 2017 Apr 28, 2017
Assets
Cash	1,691 +32.8%	1,949 -12.1%	2,218 +72.7%	1,284 -16.8%	1,543 -58.5%	3,714 +3.4%	3,593 -13.2%	4,140 -5.8%	4,393 +19.7%	3,669 -26.1%	4,967 +72.7%
Short-term investments	7,128 +4.1%	7,271 +7.8%	6,747 +0.4%	6,721 +4.8%	6,416 -6.5%	6,859 -5.1%	7,224 +6.1%	6,808 +24.8%	5,455 -27.8%	7,558 -13.5%	8,741 -10.4%
Cash and investments	8,819 +8.6%	9,220 +2.8%	8,965 +12.0%	8,005 +0.6%	7,959 -24.7%	10,573 -2.3%	10,817 -1.2%	10,948 +11.2%	9,848 -12.3%	11,227 -18.1%	13,708 +8.5%
Receivables	6,357 +1.5%	6,643 +2.0%	6,515 +6.3%	6,128 +2.2%	5,998 +8.1%	5,551 +1.6%	5,462 +17.6%	4,645 -25.3%	6,222 +3.9%	5,987 +7.1%	5,591 +0.5%
Inventory	6,215 +5.6%	5,951 +8.7%	5,476 +5.0%	5,217 -1.4%	5,293 +14.7%	4,616 +7.0%	4,313 +2.0%	4,229 +12.7%	3,753 +4.9%	3,579 +7.2%	3,338 -3.9%
Total current assets	24,390 +5.0%	24,787 +4.1%	23,814 +8.6%	21,935 +1.2%	21,675 -6.0%	23,059 +2.3%	22,548 +2.3%	22,031 +0.3%	21,967 -4.4%	22,980 -7.6%	24,873 +5.4%
Property and equipment, net	7,473 +6.7%	7,417 +8.5%	6,837 +11.5%	6,131 +10.1%	5,569 +2.9%	5,413 +3.7%	5,221 +8.1%	4,828 +3.3%	4,675 +1.5%	4,604 +5.6%	4,361 -9.9%
Goodwill	43,187 +2.8%	42,587 +2.0%	41,737 +1.8%	40,986 -1.1%	41,425 +2.3%	40,502 -3.5%	41,961 +5.3%	39,841 -0.3%	39,959 +1.1%	39,543 +2.7%	38,515 -7.2%
Total assets	93,306 +2.6%	93,028 +1.5%	91,680 +1.9%	89,981 -1.1%	90,948 -0.0%	90,981 -2.3%	93,083 +2.6%	90,689 +1.1%	89,694 -1.9%	91,393 -8.5%	99,857 +0.2%
Liabilities and equity
Accounts payable	2,695 +5.5%	2,644 +8.0%	2,449 +1.6%	2,410 -9.5%	2,662 +17.0%	2,276 +8.1%	2,106 +5.5%	1,996 +2.2%	1,953 +20.0%	1,628 +4.7%	1,555 -9.0%
Total current liabilities	11,799 +2.3%	11,658 -9.5%	12,879 +19.4%	10,789 +19.2%	9,051 -27.0%	12,394 +45.7%	8,509 -17.9%	10,366 +22.4%	8,472 -16.0%	10,084 -29.3%	14,264 +99.1%
Total liabilities	42,456 -0.9%	42,956 -1.1%	43,424 +9.8%	39,561 +0.7%	39,283 +2.7%	38,260 -7.8%	41,481 +4.2%	39,817 +0.8%	39,482 -2.7%	40,571 -18.1%	49,527 +4.1%
Stockholders' equity	50,232 +4.9%	49,463 +3.0%	48,024 -4.4%	50,214 -2.5%	51,483 -2.0%	52,551 +2.2%	51,428 +1.4%	50,737 +1.3%	50,091 -1.2%	50,720 +1.0%	50,208 -3.6%
Debt
Debt due within a year	25,565 -2.2%	26,113	0 -100.0%	1,073 -95.6%	24,280 +19.5%	20,310 -22.8%	26,307 +847.7%	2,776 +231.3%	838 -59.3%	2,058 -72.5%	7,494 +654.7%
Long-term debt	—	—	—	—	—	—	—	22,140 -9.8%	24,552 +3.6%	23,692 -8.4%	25,874 -13.6%
Lease liabilities	52 +2.0%	1,248 +6.9%	1,167 +7.6%	1,085 -2.5%	1,113 +19.3%	933 -14.1%	1,086 +9.1%	995	—	—	—
Total debt	25,617 -2.1%	27,361 +2244.6%	1,167 -45.9%	2,158 -91.5%	25,393 +19.5%	21,243 -22.5%	27,393 +5.7%	25,911 +2.1%	25,390 -1.4%	25,750 -22.8%	33,368 +7.9%
Net cash	-16,798 +7.0%	-18,141 -332.6%	7,798 +33.4%	5,847 +133.5%	-17,434 -63.4%	-10,670 +35.6%	-16,576 -10.8%	-14,963 +3.7%	-15,542 -7.0%	-14,523 +26.1%	-19,660 -7.4%
Ratios
Current ratio	2.07x	2.13x	1.85x	2.03x	2.39x	1.86x	2.65x	2.13x	2.59x	2.28x	1.74x
Debt to equity	0.51x	0.55x	0.02x	0.04x	0.49x	0.40x	0.53x	0.51x	0.51x	0.51x	0.66x
Debt to EBITDA	2.63x	2.90x	0.13x	0.28x	3.10x	2.51x	3.81x	3.48x	2.84x	2.77x	4.02x
Return on equity	10.41%	9.71%	9.71%	7.32%	7.30%	9.59%	7.01%	9.44%	9.25%	6.12%	8.02%
Return on assets	5.61%	5.16%	5.09%	4.09%	4.13%	5.54%	3.87%	5.28%	5.16%	3.40%	4.03%
Book value per share	39.24	38.64	37.46	38.29	38.69	39.49	38.23	37.83	37.36	37.45	36.66

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as: MDT (NYSE)
Fiscal year ends: April 24
Headquarters: Galway
SEC filer status: Large accelerated filer
SEC CIK: 1613103
Former names: Medtronic Ltd (until Jan 15, 2015); Medtronic Holdings Ltd (until Nov 21, 2014)

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.